FDA Inspection
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc. – FDA Inspection, May 24, 2013
Record Details
This FDA Inspection record concerns Sumitomo Pharma America, Inc., with an inspection on May 24, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 24, 2013
- Product Type
- Drugs
View Company Profile
ID · c12582b5-74d3-4a7d-a421-e9392e6a3fe4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 843011
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sumitomo Pharma America, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 2, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 5, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sumitomo Pharma America, Inc.
- FDA Inspection 1242239 - 2024-08-02
- FDA Inspection 1161579 - 2021-11-05
- FDA Inspection 915063 - 2015-01-23
- FDA Inspection 759431 - 2011-12-09
- FDA Inspection 723394 - 2011-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.